Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02148055
Other study ID # 2012/169/HP
Secondary ID
Status Terminated
Phase N/A
First received May 22, 2014
Last updated June 13, 2017
Start date May 2014
Est. completion date December 2016

Study information

Verified date June 2017
Source University Hospital, Rouen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Fetal intra uterine death is a rare event (incidence 2/1000 births) , unexpected and psychologically painful for the couple and the healthcare team. In this difficult context, it is essential to understand the etiology of death to guide the management of subsequent pregnancies. Among the investigations, foetopathologic examination is essential, but the examination of the brain is not possible in more than half of the cases due to the cerebral maceration due to the incompressible delay between death and expulsion.

The use of MRI as a diagnostic tool fetal post- mortem " virtual autopsy " performed before expulsion of the fetus is interesting because it would permit to obtain a macroscopic examination of the fetal brain, archivable, and a gain concerning the diagnosis. Thus, a normal MRI will exclude cerebral anatomical abnormality , stroke or bleeding . If MRI abnormalities are found , it will not only guide the foetopathologic review, but mainly to guide the etiology . On the other hand , it is a non-invasive tool and acceptability by the couple would be better than autopsy which is often refused by the couple in this difficult psychological context.

In this study , MRI will be given in addition to conventional autopsy in the painful waiting time between the time of diagnosis of death and expulsion without delaying care . If this study is validated , MRI may be systematically proposed in this indication or alternative to autopsy when it will be refused by the parents.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient for which he was diagnosed with intra uterine death confirmed by ultrasound

- Mono fetal pregnancy,

- Term: 24 to 42 weeks' gestation

- Age> 18 years

- Patient having readen the letter of information and signed the consent.

Exclusion Criteria:

- Contraindication to MRI (heart valve, pacemaker, neurosurgical clips, claustrophobia, intraocular metallic foreign bodies)

- Maternal complications: bleeding during, eclampsia, placental hematoma retro, imminent work

- Twin pregnancy

- Patient under guardianship or trusteeship

- Patient not speaking and writing French

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Comparaison between MR and autopsy in the macroscopic evaluation of intra uterine death.


Locations

Country Name City State
France CHU Hopitaux de Rouen Rouen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Rouen

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recognition of anatomic cerebral structures evaluated by a common grid. Before H 24 for MR. Bedore day 5 for autopsy.
Secondary Recognition and mesurement of anatomic thoracic and abdominal structures by a common grid. Before H24 for MR. Before day 5 for autopsy.
Secondary Recognition and mesurement of the placenta and umbilical cord. Before H24 for IRM. Before day 5 for autopsy.
Secondary Comparaison of quality criteria of both exams. Before H24 for MRI. Before day 5 for autopsy.